Justin Kerley’s Post

Interesting webinar coming up focused on global life science trends, including Europe.

The biotech industry has faced a 60% reduction in clinical trial initiations in 2024 compared to previous years and funding is still below 2020/21 levels. Emma Chaffin is hosting a session at #BioEurope to gain evidence-based insights from biotech leaders Anta Gkelou, Jennifer Schneider and Aneta Sottil who will share innovative strategies to navigate these hurdles. Heading to BIO-Europe? Don't miss this opportunity to gain valuable insights and book a meeting to explore how to address the pressing challenges in biotech's clinical development. https://bit.ly/4f1tibR

🌟 🚀 Stay Tuned for our big announcement in the coming weeks as we're set out to support the digital transformation of Pharma and life science industry! Exciting news coming up! 🙌 #pharmadigitaltransformation

Diversity isn’t just a goal in clinical research; it’s a necessity for success. Listen to Dr. Otis Johnson, PhD, MPA as he shares some promising new information from his recent research with Tufts Center for the Study of Drug Development and Clario.  https://lnkd.in/etm_9i3J #diversityinclinicaltrials #diversityinclinicalresearch #representationmatters #diversitymatters

🔔WCG Featured🔔 Our very own Amy Thue and Shelby Ward share their insights in Pharma Focus America!  Read their article focused on prioritizing the participation experience in #clinicaltrials to ensure a successful future of clinical research. Access now at https://lnkd.in/e-hy8QkD #clinicalresearch #retention #WCG 

Scientific exchange and real-world insights gathering fall under the purview of medical science liaisons, and their impact across the industry is strong. Syneos Health talks about how to maximize this important team in its recent webinar: https://bit.ly/3SoLZ03

By not looking ahead, we can quickly fall behind… Learn how to unleash the power of social media listening to complement traditional CI and MR by joining our Track Talk at Pharma Market Research Conference PMRC, Munich (Day 1, 5.30PM) presented by Vinayak Gokhale MD, MBA and Adam Pow #LifescienceDynamics #PMRC #PMRCEU #PharmaCIConf #PharmaCI #MarketResearch #CompetativeIntelligence

Are you tired of putting in countless hours of research only to find that your presentations at conferences fail to make a lasting impression? You're not alone. Many researchers struggle to captivate their audience and leave a lasting impact with their conference presentations. In this post, we'll uncover five key factors behind why your research might be falling short at conferences, and more importantly, how to address these challenges head-on..! Book a meeting : https://lnkd.in/gHa_fygv #MedicalCommunication #PubscriptsInnovation #publications #scientificresearch #scientificwriting #visualstorytelling #Sciencestorytelling #pharmaceuticalmanufacturing #biopharma #clinicaltrials #clinicalresearch #drugdiscovery 

Fact: Just 10-15% of new treatments successfully make it to market. Fact: With next-gen clinical development capabilities, life sciences organizations can increase their probability of success by 15% or more. In our latest POV 👇https://bit.ly/3TZXnAZ, David Ghesquieres explores how life sciences organizations can build advanced digital and data capabilities to enable innovative trial designs, driving success and time-to-market across the drug development lifecycle. #lifesciences #clinicaldevelopment #innovation

Target Product Profile (TPP) – How to make it a strategic document? That was the theme tackled last Tuesday by Carlo Chiavaroli and Karina S. from Voisin Consulting Life Sciences (VCLS) during a workshop organized at Biopôle Lausanne. What is a TPP ?  TPP summarizes all the hurdles a company would have to face from discovery to market in order to address a specific medical condition. It comprises among others pre-clinical, clinical, regulatory, market access plans, but also practical (dosage, administration…) and geographic information. TPP is an essential document applicable to all health products including #Pharma #Biotech, #Medtech and #DigitalHealth. It’s a living document that evolves with the maturation of the product development. What is the purpose of a TPP? 1 | TPP allows to coordinate different stakeholders in the company from science to business, including external stakeholders such as investors. 2 | In essence, TPP allows to define where you are heading and get on the right tracks to be faster than the competition. Want everybody in your company to be aligned? Go for your TPP(s)! Thank you Carlo, Karina and Hubert R. for sharing your expertise with such a passion!